Dallah Healthcare Company

SASE:4004 Stok Raporu

Piyasa değeri: ر.س14.9b

Dallah Healthcare Gelecekteki Büyüme

Future kriter kontrolleri 2/6

Dallah Healthcare kazanç ve gelirin sırasıyla yıllık 14.2% ve 12.7% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 11.7% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 17.2% olacağı tahmin edilmektedir.

Anahtar bilgiler

14.2%

Kazanç büyüme oranı

11.7%

EPS büyüme oranı

Healthcare kazanç büyümesi14.7%
Gelir büyüme oranı12.7%
Gelecekteki özkaynak getirisi17.2%
Analist kapsamı

Good

Son güncelleme10 Feb 2025

Gelecekteki son büyüme güncellemeleri

Dallah Healthcare Company (TADAWUL:4004) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Aug 14
Dallah Healthcare Company (TADAWUL:4004) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Recent updates

What Dallah Healthcare Company's (TADAWUL:4004) P/E Is Not Telling You

Feb 13
What Dallah Healthcare Company's (TADAWUL:4004) P/E Is Not Telling You

Investors Will Want Dallah Healthcare's (TADAWUL:4004) Growth In ROCE To Persist

Jan 08
Investors Will Want Dallah Healthcare's (TADAWUL:4004) Growth In ROCE To Persist

With EPS Growth And More, Dallah Healthcare (TADAWUL:4004) Makes An Interesting Case

Dec 21
With EPS Growth And More, Dallah Healthcare (TADAWUL:4004) Makes An Interesting Case

Some Shareholders Feeling Restless Over Dallah Healthcare Company's (TADAWUL:4004) P/E Ratio

Oct 31
Some Shareholders Feeling Restless Over Dallah Healthcare Company's (TADAWUL:4004) P/E Ratio

The Return Trends At Dallah Healthcare (TADAWUL:4004) Look Promising

Oct 07
The Return Trends At Dallah Healthcare (TADAWUL:4004) Look Promising

Do Dallah Healthcare's (TADAWUL:4004) Earnings Warrant Your Attention?

Sep 19
Do Dallah Healthcare's (TADAWUL:4004) Earnings Warrant Your Attention?

Dallah Healthcare Company (TADAWUL:4004) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Aug 14
Dallah Healthcare Company (TADAWUL:4004) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

The Price Is Right For Dallah Healthcare Company (TADAWUL:4004)

Jul 18
The Price Is Right For Dallah Healthcare Company (TADAWUL:4004)

Investors Will Want Dallah Healthcare's (TADAWUL:4004) Growth In ROCE To Persist

May 30
Investors Will Want Dallah Healthcare's (TADAWUL:4004) Growth In ROCE To Persist

We Ran A Stock Scan For Earnings Growth And Dallah Healthcare (TADAWUL:4004) Passed With Ease

Apr 16
We Ran A Stock Scan For Earnings Growth And Dallah Healthcare (TADAWUL:4004) Passed With Ease

What You Can Learn From Dallah Healthcare Company's (TADAWUL:4004) P/E

Mar 18
What You Can Learn From Dallah Healthcare Company's (TADAWUL:4004) P/E

Returns On Capital At Dallah Healthcare (TADAWUL:4004) Have Hit The Brakes

Feb 25
Returns On Capital At Dallah Healthcare (TADAWUL:4004) Have Hit The Brakes

Dallah Healthcare (TADAWUL:4004) Has More To Do To Multiply In Value Going Forward

Oct 30
Dallah Healthcare (TADAWUL:4004) Has More To Do To Multiply In Value Going Forward

Dallah Healthcare (TADAWUL:4004) Is Reinvesting At Lower Rates Of Return

Jul 26
Dallah Healthcare (TADAWUL:4004) Is Reinvesting At Lower Rates Of Return

Returns On Capital Signal Tricky Times Ahead For Dallah Healthcare (TADAWUL:4004)

Apr 17
Returns On Capital Signal Tricky Times Ahead For Dallah Healthcare (TADAWUL:4004)

Is Now The Time To Put Dallah Healthcare (TADAWUL:4004) On Your Watchlist?

Feb 06
Is Now The Time To Put Dallah Healthcare (TADAWUL:4004) On Your Watchlist?

Dallah Healthcare (TADAWUL:4004) Will Want To Turn Around Its Return Trends

Dec 05
Dallah Healthcare (TADAWUL:4004) Will Want To Turn Around Its Return Trends

We Ran A Stock Scan For Earnings Growth And Dallah Healthcare (TADAWUL:4004) Passed With Ease

Nov 01
We Ran A Stock Scan For Earnings Growth And Dallah Healthcare (TADAWUL:4004) Passed With Ease

Calculating The Intrinsic Value Of Dallah Healthcare Company (TADAWUL:4004)

Aug 28
Calculating The Intrinsic Value Of Dallah Healthcare Company (TADAWUL:4004)

Dallah Healthcare (TADAWUL:4004) Has Some Way To Go To Become A Multi-Bagger

Aug 12
Dallah Healthcare (TADAWUL:4004) Has Some Way To Go To Become A Multi-Bagger

Here's Why We Think Dallah Healthcare (TADAWUL:4004) Is Well Worth Watching

Jul 28
Here's Why We Think Dallah Healthcare (TADAWUL:4004) Is Well Worth Watching

Industry Analysts Just Upgraded Their Dallah Healthcare Company (TADAWUL:4004) Revenue Forecasts By 10%

May 26
Industry Analysts Just Upgraded Their Dallah Healthcare Company (TADAWUL:4004) Revenue Forecasts By 10%

Calculating The Fair Value Of Dallah Healthcare Company (TADAWUL:4004)

May 20
Calculating The Fair Value Of Dallah Healthcare Company (TADAWUL:4004)

Here's Why We Think Dallah Healthcare (TADAWUL:4004) Is Well Worth Watching

Apr 16
Here's Why We Think Dallah Healthcare (TADAWUL:4004) Is Well Worth Watching

Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively

Feb 03
Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively

Is Now The Time To Put Dallah Healthcare (TADAWUL:4004) On Your Watchlist?

Jan 10
Is Now The Time To Put Dallah Healthcare (TADAWUL:4004) On Your Watchlist?

Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively

Oct 19
Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively

Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively

Jul 09
Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively

Forecast: Analysts Think Dallah Healthcare Company's (TADAWUL:4004) Business Prospects Have Improved Drastically

Jun 16
Forecast: Analysts Think Dallah Healthcare Company's (TADAWUL:4004) Business Prospects Have Improved Drastically

Broker Revenue Forecasts For Dallah Healthcare Company (TADAWUL:4004) Are Surging Higher

May 02
Broker Revenue Forecasts For Dallah Healthcare Company (TADAWUL:4004) Are Surging Higher

What Kind Of Shareholders Hold The Majority In Dallah Healthcare Company's (TADAWUL:4004) Shares?

Mar 17
What Kind Of Shareholders Hold The Majority In Dallah Healthcare Company's (TADAWUL:4004) Shares?

Has Dallah Healthcare (TADAWUL:4004) Got What It Takes To Become A Multi-Bagger?

Mar 02
Has Dallah Healthcare (TADAWUL:4004) Got What It Takes To Become A Multi-Bagger?

Dallah Healthcare (TADAWUL:4004) Shareholders Booked A 45% Gain In The Last Year

Feb 15
Dallah Healthcare (TADAWUL:4004) Shareholders Booked A 45% Gain In The Last Year

Should You Buy Dallah Healthcare Company (TADAWUL:4004) For Its Dividend?

Feb 01
Should You Buy Dallah Healthcare Company (TADAWUL:4004) For Its Dividend?

Are Dallah Healthcare's (TADAWUL:4004) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Jan 05
Are Dallah Healthcare's (TADAWUL:4004) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Dallah Healthcare Company's (TADAWUL:4004) Intrinsic Value Is Potentially 26% Below Its Share Price

Dec 22
Dallah Healthcare Company's (TADAWUL:4004) Intrinsic Value Is Potentially 26% Below Its Share Price

Will Dallah Healthcare (TADAWUL:4004) Multiply In Value Going Forward?

Nov 20
Will Dallah Healthcare (TADAWUL:4004) Multiply In Value Going Forward?

Kazanç ve Gelir Büyüme Tahminleri

SASE:4004 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (SAR Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/20275,0587908791,0863
12/31/20264,2256296559787
12/31/20253,8395353167427
12/31/20243,3214942716436
9/30/20243,203471358779N/A
6/30/20243,105444326667N/A
3/31/20243,010385415724N/A
12/31/20232,943360329626N/A
9/30/20232,831325348562N/A
6/30/20232,682270369549N/A
3/31/20232,595286333519N/A
12/31/20222,488274267442N/A
9/30/20222,370305214367N/A
6/30/20222,313311122260N/A
3/31/20222,220289166290N/A
12/31/20212,105259246362N/A
9/30/20211,935202178305N/A
6/30/20211,742206240363N/A
3/31/20211,498165110215N/A
12/31/20201,31813254183N/A
9/30/20201,25715082211N/A
6/30/20201,20712335198N/A
3/31/20201,24613133244N/A
12/31/20191,252147106307N/A
9/30/20191,22711088290N/A
6/30/20191,20611543264N/A
3/31/20191,1931195255N/A
12/31/20181,181142-51204N/A
9/30/20181,189172-158184N/A
6/30/20181,203217N/A253N/A
3/31/20181,218268N/A297N/A
12/31/20171,212295N/A353N/A
9/30/20171,202284N/A457N/A
6/30/20171,180268N/A387N/A
3/31/20171,181252N/A382N/A
12/31/20161,163225N/A343N/A
9/30/20161,122228N/A244N/A
6/30/20161,073194N/A261N/A
3/31/20161,030175N/A233N/A
12/31/2015985165N/A214N/A
9/30/2015948161N/A204N/A
6/30/2015917156N/A168N/A
3/31/2015892154N/A151N/A
12/31/2014859147N/A149N/A
9/30/2014831149N/A137N/A
6/30/2014805149N/A138N/A
3/31/2014773138N/A108N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: 4004 'nin tahmini kazanç büyümesi (yıllık 14.2% ) tasarruf oranının ( 14.9% ) altındadır.

Kazançlar ve Piyasa: 4004 şirketinin kazançlarının (yıllık 14.2% ) SA pazarından (yıllık 5.9% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Kazançları: 4004 şirketinin kazançlarının artması bekleniyor, ancak önemli ölçüde.

Gelir ve Pazar: 4004 şirketinin gelirinin (yıllık 12.7% ) SA pazarından (yıllık -0.6% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Geliri: 4004 şirketinin gelirinin (yıllık 12.7% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: 4004 'nin Özsermaye Getirisi'nin 3 yıl içinde düşük olması tahmin ediliyor ( 17.2 %).

Büyüyen şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y

Şirket Analizi ve Finansal Veri Durumu

VeriSon Güncelleme (UTC saati)
Şirket Analizi2025/02/16 16:29
Gün Sonu Hisse Fiyatı2025/02/16 00:00
Kazançlar2024/09/30
Yıllık Kazançlar2023/12/31

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

PaketVeriZaman ÇerçevesiÖrnek ABD Kaynağı *
Şirket Finansalları10 yıl
  • Gelir tablosu
  • Nakit akış tablosu
  • Bilanço
Analist Konsensüs Tahminleri+3 yıl
  • Finansal tahminler
  • Analist fiyat hedefleri
Piyasa Fiyatları30 yıl
  • Hisse senedi fiyatları
  • Temettüler, Bölünmeler ve Eylemler
Sahiplik10 yıl
  • En büyük hissedarlar
  • İçeriden öğrenenlerin ticareti
Yönetim10 yıl
  • Liderlik ekibi
  • Yönetim Kurulu
Önemli Gelişmeler10 yıl
  • Şirket duyuruları

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntıları Github sayfamızda mevcuttur, ayrıca raporlarımızın nasıl kullanılacağına dair kılavuzlarımız ve Youtube'da eğitimlerimiz bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.

Analist Kaynakları

Dallah Healthcare Company 22 Bu analistlerden 7, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

AnalistKurum
Ibrahim ElaiwatAljazira Capital Company
Jassim Al-JubranAljazira Capital Company
Rim Ben Salah GharbiAlphaMena